{"ticker": {"uuid": "e419ff99-698b-4a4e-9604-a8e68e11351f", "symbol": "LCTX", "name": "Lineage Cell Therapeutics, Inc.", "exchange": "TLV", "country": "IL", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Lineage Cell Therapeutics Inc (LCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1EbFhXeE02LUViWnczdnh3Qml0QWp5dWJqcU1fdTEyYkM5LWZFdTE0Sk1iSGpLLXNyajhFX283UlNHckpkVjd3VmttaXNvd2FmTVNxN2swdk04em5IendJdW9pRnhENzFaQmtwR1dibXFEYjRTLWpXWg?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T19:15:24+00:00", "published_display": "18 Jun 2026 19:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQenBlRTFvV09SeVdKUC1aWGtPUVhLckJKSUtUazd2X2NKb3o1blBqRzU0Rk56VTRmZmg1MzZQbDZOMi0zVVplSkxvYmxYSnBtbk9QQnJaRmNLbXYxaVhWYUxiMXUtRHo5QWtISUw2ZmR4VXZYMk1Dc05QdjBtNlJVa0pZZWgwcUZwbFBqaW1zM1VtbURyT05uT2pqUjd4NXEwX0lN?oc=5", "source_name": "Market source", "published_at": "2026-06-18T16:20:49+00:00", "published_display": "18 Jun 2026 16:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Inc (LCTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9PT2RyNmg3UEN6WGhXM3l1R3A5SnVRYjJoV25xYlJ6MktmTnR0MmVVZ2Z4WWlmWHN2Zk44M0NJa1JMZ0luaV93LVZuWHZjRmxqeDR3cWJpQjEtU3ZELUxadUJFSFhkQXdIVlhMc29BVmU?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T06:12:43+00:00", "published_display": "18 Jun 2026 06:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Inc (LCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5QSWM0Zm5FRHdmRlk0VXh6V203NWJuaTkyUFZTRjVxaGtYOExoSVQ4MldaMWkwQlBlUWpVSXFySC0wSlM0Q1BiYVI4M1MwUnZoVWREMVhEeEZBUGh5T0hJcmFHZzlMN3JMNGhjTEdQOA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T03:30:52+00:00", "published_display": "18 Jun 2026 03:30", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Inc (LCTX) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9VTHlnMEJUeWZXMXNkZlVOOXBkbXFlRFAwcDBsQmtXdGxxekF2SW1Jb3FmcXFUVlV5WlVnY1FfTkQ0b2Z2QWwwUXdDV3h6SFh0OUp3R2U0N1lUbmczcG1KRG5MRThMX1ItZUE1b05GMUM?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:21:34+00:00", "published_display": "18 Jun 2026 01:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Inc (LCTX) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1Tcjk0MjJ3MjRXWnFGbHlJMldIaEtROFlMQnVOeDhnc2hFaWNHQmFKOG50Zk9Oc0k2QmQtREdTZEVOSlh1Um1IT1BtYmQ1VEhvaEFjbGJDcWJTWEtfSkYxcm1PVndiWnBXaXdtOFAwam9xYThQeHJpSTBadw?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:06:22+00:00", "published_display": "18 Jun 2026 01:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Shareholders Reaffirm Governance and Executive Pay", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPU3h3N3VKUDg1UzZfVUxrbG9JZ2VKMDg2cVRtUnNzUUhMSDRUWU42aEVwWEI3MjFISTMxdGttNWpObVc4RXRtRk1UYUd6cWFiT2RDaGI5aVdyWVRrbkdCRlRON29jd0M1aEhtZjV4QjlsSUJUMnNLV0JmQ2FPRXdheXpDOGNsUzM1cDR5aUFRcjZYTlA5MWhXcnowOGRuSEFITFAweGNqaVZSZUMxd3FtcTMzbk5WcDYtdjNTMllERU93dUJ6ck1EZUNhMW42NUpBcmxzcUg5TVV2RWttUWREWVdn?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-13T23:04:00+00:00", "published_display": "13 Jun 2026 23:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell (NYSE: LCTX) investors back board, say-on-pay as OPC1 grant bid withdrawn", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQZE5La2loTFlEVE5pYkVOLWZxM0VoOGQwZlZHenVQbDhYS3VQR1ZRcUxoVHF4bkJ1YzJfemN3YUxXWGZTc2didFlUbTlBZVhGYmxIR1FaakpPeGF3R3BGbndTRE5CTzdIeUEyMi1wRllPTE1XSEVSX2ZxNjJRYXZGZ1EtZVFRcE1VR205M0VfMThhU29xWWp3X2dMVXNGUVQtY3E3SWlpLTBzT1ktWXpyczlVT2FVbkRkWlE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T20:32:03+00:00", "published_display": "12 Jun 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZTA0SlpmdDRHalpCcmlxemNxRldKc1NuOC1YaTJxWVNJdDU1RnhjaFY2aWQyaG9MbUZVMk5mS1RydHBYSGI0ZUF1d19scjVmN2hxYVdJa3V3M2p5MlRKbUZDUGE5Z25GQ0ZsQXRwSTZjVEdfVHRYUFROYk5TM0Nqb2VCRW9GMm1qWFRWN1lXamtpZ1hkX1BwcVQ2Z3BHLUdyM0dUWVRxanA?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPYk5tRElyQlBDVWU5Mlh1N2Q0LTJTOG5qN281ZXNuTFhNUnpEVkQzY0Zva05uRGs5YS1rODlUODVDOEJxWHBDVGdYeDRNdmQybEhyMWlCT05WRS1EaWFYTk54X3lhbEh0VzFPZkJHN284VlNyZlJtM2NEU0hrUU9zQUVuWms3a3ozUG8zRjBic2g4S0pGVWU4VHZ3SHZGMjU2dDZ4U3d5Vm5zdTZVcFBCSGZqOFE1UFo2dVpfWnpNSXJTeTgwT290WkFjMktxbDVzdEIycmt2cEE0VGh4bVFIMFEwS2htbXMteXRWQg?oc=5", "source_name": "Business Wire", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE56LUJUR0plYWdvQWVja0tiQ19CUG9QczgwVVEtUVEtbnRxekVRSi1pMVYtSWVuZkhNUDN2Q2FkRDVnc1dCVUVmMlJTZ3lyMW5PVjliekxneUkxOHRwVGNoendEanVvZmw1c3NBdTRfc0JxQmZnS3ZnQ2dORW9pbFE?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage adds 2 biotech veterans to steer its cell therapy pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOa01fVVRuNzl3STdSTnpNUEU4RnRwY3hFV0NjbUpIVmNHcGpDSDh0eDlBV3J3dGN6Q1R2QlZfSW5uUWczQm9mRXMyS1ptZDRVS1dCRDk3bzh4eEN2YzI4ZTVJeFUzVHdsSE9ieVlSQ0VfNEtxanExa1FndGR2V3VWYnRSdmE4MVA1SVZaYzFoTjI4SjJ6YzgyUTd0MlBVRE9Za1EyOFZEQlg?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell (LCTX) Launches Its Latest Cell Therapy Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZUZtN2RNeW9nMmpxdHJ6Z0docEY2MUQwOFYxNUh2d0JNbFlVSnlJZFNPSDhSX1N1endvZzJfeEF6RjltMGNhdVVkTW9tX2ZWeUh5emU2UzFUekhnZk1nRlczbjN3SElQYWZkRGZPOE1ZRnRWd0R6bnZfaTVzMEpTOXJBYUJJb0RiMEhPUFBnZVEycGc3bjZCc2hjbjFzZ0ljSnptZg?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage targets corneal disease with lab-made cells amid donor shortage", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUjYyMnp3YU9Gb0lhOVZURDZTNmZVb1RYUzBjdGxTU05DOXV1WVhpYThMZlJkOV8yQkRLMkVJS1QwSWdwLVNONkRpZDhkOXNOcGtOS1JnU1E3V3hmZ0c2OEEyLXJGNC1mN1VhdzR0ODNGLXFIeE5OaEpraEtrd2dLT3dFOUw0YlMyVWJDcXU3N1YwYXViejBhZXVJUGdvME85aTJ2bHVabmlTVVlBYTNrY3ZSNHppM3FQMVIw?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] Lineage Cell Therapeutics, Inc. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOUWk0UUVhTXQtaFFBRWYzYkRiR2o5LTNBcnV0NXZzU19mVVduN1VIT253M3R0b2w5UUxVZ3ZuU1pnVlBDdEtOeC10LWNnYmxiSUh2M3dyWVh1QUZEODJNMEp2enk3dFFmSTF1ZDA3b2xFWnlSNi1KMUZWTzd0X3pxRU9JVDBwc3ZCU1NhVUpleWtJcmdrYThNUFRlV1BZYjM1VlpUS3lIYWJrYnpKLWc?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Brian Culley Acquires 15,000 Shares of Lineage C", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQWkpmR21TSEwzQkdMQllkVGtlcEhrVl9HMXVMZ3pkeFdRbndZSzRDczhPNDhfcVZic0ZDenM4X2I1T1pLdDNZcTl2am1vZFlQZWphcG5rMDJ2RHMxYk41dGdhWWs1LW5lbE9vUjhMQ2Z5RlhHYzRHdWxaTkZrMWE3OEtWZTFFOGlDaWdkaV8wUEhrSFR3aHdZVEtMemlRS2pIWG9aRHN6dHpFR3lIVFNDb0RtUFN4TWxlSE9GMlNqSmdJNlMxa3FEWk1URXVPb3VJdUl0MA?oc=5", "source_name": "GuruFocus", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQZDNOSTgtRktDTWRLTHpSUElhdmNZNm5pbXZpMHZSc21uRS05eURreE5zSngxRkdnZVExUFhEZjMwZXFJdVpFMHFIRXBiV3h4UXZMNUtwcE9GV0hxSVRxeXBlQ1htcWpwZDUzdlBaN3ZjNjlrT1RzT2F5bnlWdmR6ei0yMDdmSXo1R3BfOW41MEZlalBjTHNJbWxWemtDZlFWQmIwVnJHZUczaGRhYXhTekIwOVNjYTZjUzQ1UGJSVkVUOVVMQ1dCYWQxeGVaNXRTYzZCdUMyY3BPa2lpdTZPcU1IcDhHRk1FZ1JOdkxKMkpsRnNhNlVFaWVWVTVUQ05x?oc=5", "source_name": "Business Wire", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell schedules Q4 and full-year 2025 results call for March 5", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQN25sN3RNR3o4MWJjLWU0TVB2V1AtNkZqRnQ2YVJON0dVRnBxeFBubDJHcTgxUHI1dGM3Q0JTY3VObVRIVGs1T1FJVldVLWdIdWFjRm5YU09Jbm5uU1p1WlRRZHZRcll6ZHJNUmRVcHZVMU1xd1JwcWdPdmtrT1pCcmVHTmViRmpBemZwNVhRcGI1dGowOFZuanRMblNJbDdOcXMzSGpqQkJaaG5USUhTelN0QTcxOTk1SkxF?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxObjBBM2p3N1pKT3IyREN5TXh5MjA1RFNFV3MwdGpyZ0RNU0xFbWtmbkl6MTQzNUhmZ2hjSVZjYWIyWEd4bXVYVWE3T1BkZEhiMDQ0dlN2TjRUTFdaUE93VmpDblhFRWR2UThsa0Q1bWJxTWk5Z0IzaWhobFljSFFtNU1kclFIZ00?oc=5", "source_name": "Market source", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance\u2122 (ANP1) for Hearing Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxQdmw5QVJLUWdic3hyczdadVZYQ2JnZ2h6azFLXzZRWElFREZfSU52NEthWGtod2EySmxPMkozaUlaTEdHMmxJdUNPTV9UbUltNVIyVDQyajFYZ1JqdFJsb2hIU1I4YW9nNk9la2x6OHdkZFdMVm1aRWQzUGxsbXJiWFc1S1haRGZ0aTVvZGtaOGpRVE95T25ua1FYTmxvNm5lVTI5Q0NxLWZidlZZRHlWTng3cFlkQjJJNVRiNDhmbzlKLV9XSzktZnFiakprWWpTMnltVi1IbHhvMklkV21XSU1icmloWFNZUU9QX2FDN2IzWDR0OThpV2tkcw?oc=5", "source_name": "Business Wire", "published_at": "2025-08-26T07:00:00+00:00", "published_display": "26 Aug 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Lineage Cell Therapeutics Inc (LCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE1EbFhXeE02LUViWnczdnh3Qml0QWp5dWJqcU1fdTEyYkM5LWZFdTE0Sk1iSGpLLXNyajhFX283UlNHckpkVjd3VmttaXNvd2FmTVNxN2swdk04em5IendJdW9pRnhENzFaQmtwR1dibXFEYjRTLWpXWg?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T19:15:24+00:00", "published_display": "18 Jun 2026 19:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQenBlRTFvV09SeVdKUC1aWGtPUVhLckJKSUtUazd2X2NKb3o1blBqRzU0Rk56VTRmZmg1MzZQbDZOMi0zVVplSkxvYmxYSnBtbk9QQnJaRmNLbXYxaVhWYUxiMXUtRHo5QWtISUw2ZmR4VXZYMk1Dc05QdjBtNlJVa0pZZWgwcUZwbFBqaW1zM1VtbURyT05uT2pqUjd4NXEwX0lN?oc=5", "source_name": "Market source", "published_at": "2026-06-18T16:20:49+00:00", "published_display": "18 Jun 2026 16:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Inc (LCTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9PT2RyNmg3UEN6WGhXM3l1R3A5SnVRYjJoV25xYlJ6MktmTnR0MmVVZ2Z4WWlmWHN2Zk44M0NJa1JMZ0luaV93LVZuWHZjRmxqeDR3cWJpQjEtU3ZELUxadUJFSFhkQXdIVlhMc29BVmU?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T06:12:43+00:00", "published_display": "18 Jun 2026 06:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Inc (LCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5QSWM0Zm5FRHdmRlk0VXh6V203NWJuaTkyUFZTRjVxaGtYOExoSVQ4MldaMWkwQlBlUWpVSXFySC0wSlM0Q1BiYVI4M1MwUnZoVWREMVhEeEZBUGh5T0hJcmFHZzlMN3JMNGhjTEdQOA?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T03:30:52+00:00", "published_display": "18 Jun 2026 03:30", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Inc (LCTX) Institutional Confidence", "summary": "", "url": "https://news.google.com/rss/articles/CBMicEFVX3lxTE9VTHlnMEJUeWZXMXNkZlVOOXBkbXFlRFAwcDBsQmtXdGxxekF2SW1Jb3FmcXFUVlV5WlVnY1FfTkQ0b2Z2QWwwUXdDV3h6SFh0OUp3R2U0N1lUbmczcG1KRG5MRThMX1ItZUE1b05GMUM?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:21:34+00:00", "published_display": "18 Jun 2026 01:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Inc (LCTX) Valuation: PE, PB & Fair Value Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1Tcjk0MjJ3MjRXWnFGbHlJMldIaEtROFlMQnVOeDhnc2hFaWNHQmFKOG50Zk9Oc0k2QmQtREdTZEVOSlh1Um1IT1BtYmQ1VEhvaEFjbGJDcWJTWEtfSkYxcm1PVndiWnBXaXdtOFAwam9xYThQeHJpSTBadw?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:06:22+00:00", "published_display": "18 Jun 2026 01:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Shareholders Reaffirm Governance and Executive Pay", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPU3h3N3VKUDg1UzZfVUxrbG9JZ2VKMDg2cVRtUnNzUUhMSDRUWU42aEVwWEI3MjFISTMxdGttNWpObVc4RXRtRk1UYUd6cWFiT2RDaGI5aVdyWVRrbkdCRlRON29jd0M1aEhtZjV4QjlsSUJUMnNLV0JmQ2FPRXdheXpDOGNsUzM1cDR5aUFRcjZYTlA5MWhXcnowOGRuSEFITFAweGNqaVZSZUMxd3FtcTMzbk5WcDYtdjNTMllERU93dUJ6ck1EZUNhMW42NUpBcmxzcUg5TVV2RWttUWREWVdn?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-13T23:04:00+00:00", "published_display": "13 Jun 2026 23:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell (NYSE: LCTX) investors back board, say-on-pay as OPC1 grant bid withdrawn", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQZE5La2loTFlEVE5pYkVOLWZxM0VoOGQwZlZHenVQbDhYS3VQR1ZRcUxoVHF4bkJ1YzJfemN3YUxXWGZTc2didFlUbTlBZVhGYmxIR1FaakpPeGF3R3BGbndTRE5CTzdIeUEyMi1wRllPTE1XSEVSX2ZxNjJRYXZGZ1EtZVFRcE1VR205M0VfMThhU29xWWp3X2dMVXNGUVQtY3E3SWlpLTBzT1ktWXpyczlVT2FVbkRkWlE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T20:32:03+00:00", "published_display": "12 Jun 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZTA0SlpmdDRHalpCcmlxemNxRldKc1NuOC1YaTJxWVNJdDU1RnhjaFY2aWQyaG9MbUZVMk5mS1RydHBYSGI0ZUF1d19scjVmN2hxYVdJa3V3M2p5MlRKbUZDUGE5Z25GQ0ZsQXRwSTZjVEdfVHRYUFROYk5TM0Nqb2VCRW9GMm1qWFRWN1lXamtpZ1hkX1BwcVQ2Z3BHLUdyM0dUWVRxanA?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPYk5tRElyQlBDVWU5Mlh1N2Q0LTJTOG5qN281ZXNuTFhNUnpEVkQzY0Zva05uRGs5YS1rODlUODVDOEJxWHBDVGdYeDRNdmQybEhyMWlCT05WRS1EaWFYTk54X3lhbEh0VzFPZkJHN284VlNyZlJtM2NEU0hrUU9zQUVuWms3a3ozUG8zRjBic2g4S0pGVWU4VHZ3SHZGMjU2dDZ4U3d5Vm5zdTZVcFBCSGZqOFE1UFo2dVpfWnpNSXJTeTgwT290WkFjMktxbDVzdEIycmt2cEE0VGh4bVFIMFEwS2htbXMteXRWQg?oc=5", "source_name": "Business Wire", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE56LUJUR0plYWdvQWVja0tiQ19CUG9QczgwVVEtUVEtbnRxekVRSi1pMVYtSWVuZkhNUDN2Q2FkRDVnc1dCVUVmMlJTZ3lyMW5PVjliekxneUkxOHRwVGNoendEanVvZmw1c3NBdTRfc0JxQmZnS3ZnQ2dORW9pbFE?oc=5", "source_name": "Market source", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage adds 2 biotech veterans to steer its cell therapy pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOa01fVVRuNzl3STdSTnpNUEU4RnRwY3hFV0NjbUpIVmNHcGpDSDh0eDlBV3J3dGN6Q1R2QlZfSW5uUWczQm9mRXMyS1ptZDRVS1dCRDk3bzh4eEN2YzI4ZTVJeFUzVHdsSE9ieVlSQ0VfNEtxanExa1FndGR2V3VWYnRSdmE4MVA1SVZaYzFoTjI4SjJ6YzgyUTd0MlBVRE9Za1EyOFZEQlg?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell (LCTX) Launches Its Latest Cell Therapy Program", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZUZtN2RNeW9nMmpxdHJ6Z0docEY2MUQwOFYxNUh2d0JNbFlVSnlJZFNPSDhSX1N1endvZzJfeEF6RjltMGNhdVVkTW9tX2ZWeUh5emU2UzFUekhnZk1nRlczbjN3SElQYWZkRGZPOE1ZRnRWd0R6bnZfaTVzMEpTOXJBYUJJb0RiMEhPUFBnZVEycGc3bjZCc2hjbjFzZ0ljSnptZg?oc=5", "source_name": "Market source", "published_at": "2026-03-31T07:00:00+00:00", "published_display": "31 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage targets corneal disease with lab-made cells amid donor shortage", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUjYyMnp3YU9Gb0lhOVZURDZTNmZVb1RYUzBjdGxTU05DOXV1WVhpYThMZlJkOV8yQkRLMkVJS1QwSWdwLVNONkRpZDhkOXNOcGtOS1JnU1E3V3hmZ0c2OEEyLXJGNC1mN1VhdzR0ODNGLXFIeE5OaEpraEtrd2dLT3dFOUw0YlMyVWJDcXU3N1YwYXViejBhZXVJUGdvME85aTJ2bHVabmlTVVlBYTNrY3ZSNHppM3FQMVIw?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[EFFECT] Lineage Cell Therapeutics, Inc. SEC Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOUWk0UUVhTXQtaFFBRWYzYkRiR2o5LTNBcnV0NXZzU19mVVduN1VIT253M3R0b2w5UUxVZ3ZuU1pnVlBDdEtOeC10LWNnYmxiSUh2M3dyWVh1QUZEODJNMEp2enk3dFFmSTF1ZDA3b2xFWnlSNi1KMUZWTzd0X3pxRU9JVDBwc3ZCU1NhVUpleWtJcmdrYThNUFRlV1BZYjM1VlpUS3lIYWJrYnpKLWc?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Brian Culley Acquires 15,000 Shares of Lineage C", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQWkpmR21TSEwzQkdMQllkVGtlcEhrVl9HMXVMZ3pkeFdRbndZSzRDczhPNDhfcVZic0ZDenM4X2I1T1pLdDNZcTl2am1vZFlQZWphcG5rMDJ2RHMxYk41dGdhWWs1LW5lbE9vUjhMQ2Z5RlhHYzRHdWxaTkZrMWE3OEtWZTFFOGlDaWdkaV8wUEhrSFR3aHdZVEtMemlRS2pIWG9aRHN6dHpFR3lIVFNDb0RtUFN4TWxlSE9GMlNqSmdJNlMxa3FEWk1URXVPb3VJdUl0MA?oc=5", "source_name": "GuruFocus", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQZDNOSTgtRktDTWRLTHpSUElhdmNZNm5pbXZpMHZSc21uRS05eURreE5zSngxRkdnZVExUFhEZjMwZXFJdVpFMHFIRXBiV3h4UXZMNUtwcE9GV0hxSVRxeXBlQ1htcWpwZDUzdlBaN3ZjNjlrT1RzT2F5bnlWdmR6ei0yMDdmSXo1R3BfOW41MEZlalBjTHNJbWxWemtDZlFWQmIwVnJHZUczaGRhYXhTekIwOVNjYTZjUzQ1UGJSVkVUOVVMQ1dCYWQxeGVaNXRTYzZCdUMyY3BPa2lpdTZPcU1IcDhHRk1FZ1JOdkxKMkpsRnNhNlVFaWVWVTVUQ05x?oc=5", "source_name": "Business Wire", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell schedules Q4 and full-year 2025 results call for March 5", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQN25sN3RNR3o4MWJjLWU0TVB2V1AtNkZqRnQ2YVJON0dVRnBxeFBubDJHcTgxUHI1dGM3Q0JTY3VObVRIVGs1T1FJVldVLWdIdWFjRm5YU09Jbm5uU1p1WlRRZHZRcll6ZHJNUmRVcHZVMU1xd1JwcWdPdmtrT1pCcmVHTmViRmpBemZwNVhRcGI1dGowOFZuanRMblNJbDdOcXMzSGpqQkJaaG5USUhTelN0QTcxOTk1SkxF?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxObjBBM2p3N1pKT3IyREN5TXh5MjA1RFNFV3MwdGpyZ0RNU0xFbWtmbkl6MTQzNUhmZ2hjSVZjYWIyWEd4bXVYVWE3T1BkZEhiMDQ0dlN2TjRUTFdaUE93VmpDblhFRWR2UThsa0Q1bWJxTWk5Z0IzaWhobFljSFFtNU1kclFIZ00?oc=5", "source_name": "Market source", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance\u2122 (ANP1) for Hearing Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxQdmw5QVJLUWdic3hyczdadVZYQ2JnZ2h6azFLXzZRWElFREZfSU52NEthWGtod2EySmxPMkozaUlaTEdHMmxJdUNPTV9UbUltNVIyVDQyajFYZ1JqdFJsb2hIU1I4YW9nNk9la2x6OHdkZFdMVm1aRWQzUGxsbXJiWFc1S1haRGZ0aTVvZGtaOGpRVE95T25ua1FYTmxvNm5lVTI5Q0NxLWZidlZZRHlWTng3cFlkQjJJNVRiNDhmbzlKLV9XSzktZnFiakprWWpTMnltVi1IbHhvMklkV21XSU1icmloWFNZUU9QX2FDN2IzWDR0OThpV2tkcw?oc=5", "source_name": "Business Wire", "published_at": "2025-08-26T07:00:00+00:00", "published_display": "26 Aug 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 74, "total_relevant": 20, "sentiment_summary": {"positive": 2, "negative": 2, "neutral": 16, "score": 51, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 7.15, "count": 13}, {"event": "earnings", "label": "Earnings", "weight": 2.75, "count": 5}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}], "positive_events": 2, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 363.5, "latest_week": "2026-06-19", "one_week_move": -8.4, "four_week_move": 8822.4, "twelve_week_move": 7194.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.817692, "market_dynamics_buy_signal": false, "relative_strength": 1314.05898, "fair_value_gap": 3199.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.366, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-8.4% over one week, +8822.4% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingKey", "count": 5}, {"label": "Market source", "count": 5}, {"label": "Stock Titan", "count": 5}, {"label": "Business Wire", "count": 3}, {"label": "The Globe and Mail", "count": 1}, {"label": "GuruFocus", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Earnings", "count": 5}, {"label": "Analyst action", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-8.4% over one week, +8822.4% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Lineage Cell Therapeutics Inc (LCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline"}], "updated_at": "2026-06-22T20:57:46.569204+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}